Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer.

Bhattacharyya, G S; Walia, M; Nandi, M; Murli, A; Salim, S; Rajpurohit, S; Shinde, S; Aggarwal, S; Parikh, P M

Bhattacharyya, G S; Walia, M; Nandi, M; Murli, A; Salim, S; Rajpurohit, S; Shinde, S; Aggarwal, S; Parikh, P M.

Afiliação

Bhattacharyya GS; Department of Medical Oncology, Fortis Hospital, Kolkata, West Bengal, India.
Walia M; Department of Medical Oncology, Max Hospital, New Delhi, India.
Nandi M; Department of Medical Oncology, Jaypee Hospital, Noida, Uttar Pradesh, India.
Murli A; Department of Medical Oncology, Sarvodaya Hospital, Faridabad, Haryana, India.
Salim S; Department of Oncology, Hakim Sanaullah Cancer Center, Sopore, Jammu and Kashmir, India.
Rajpurohit S; Department of Medical Oncology, RGCI, New Delhi, India.
Shinde S; Department of Medical Oncology, Sir Ganga Ram Hospital, New Delhi, India.
Aggarwal S; Department of Medical Oncology, Sir Ganga Ram Hospital, New Delhi, India.
Parikh PM; Department of Oncology, Shalby Cancer and Research Institute, Mumbai, Maharashtra, India.

South Asian J Cancer ; 7(2): 156-158, 2018.

Article em En | MEDLINE | ID: mdl-29721485

Palavras-chave

Anthracycline; BCS; BRCA; SLNB; carboplatin; elderly; radiotherapy; taxane; tumor size

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: South Asian J Cancer Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Índia País de publicação: Índia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google